Markets › India › NSE › LALPATHLAB

Dr. Lal PathLabs Ltd

NSE:LALPATHLABHealthcareNSE:CNX500NSE:CNXSMALLCAP

₹1,843.70−0.87%At closeAt close · Mon 19 Oct · ≈ AED 71.14 · Market cap $3.28B · Next earnings Wed 4 Nov

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	62.0%	75.9%	63.8%	65.7%	66.6%	42.0%	—	—
Operating margin	23.0%	35.3%	17.4%	21.0%	22.8%	22.5%	22.5%	+0.0 pts
Net margin	18.4%	16.5%	11.8%	16.1%	19.8%	18.3%	18.3%	+0.0 pts
EBITDA margin	30.8%	29.4%	26.4%	30.5%	32.0%	30.9%	—	—
Return on equity	23.4%	22.9%	14.3%	19.3%	22.4%	20.1%	19.9%	−0.3 pts
Return on assets	17.6%	14.7%	10.0%	14.6%	17.9%	16.0%	16.0%	+0.0 pts
Return on capital employed	26.3%	39.8%	18.3%	23.5%	24.2%	23.0%	—	—
Debt / equity	0.1×	0.4×	0.3×	0.1×	0.1×	0.1×	0.1×	−1.3%
Debt / assets	9.1%	22.6%	17.6%	10.1%	5.8%	6.3%	—	—
Interest coverage	22.8×	24.4×	9.4×	15.9×	25.1×	27.2×	—	—
Current ratio	4.2×	1.8×	2.1×	2.4×	3.4×	3.5×	3.5×	+0.0%
Quick ratio	4.0×	1.6×	2.0×	2.3×	3.3×	3.4×	—	—
Cash ratio	0.9×	0.8×	0.6×	0.8×	0.7×	2.0×	2.0×	+0.0%
Asset turnover	1.0×	0.9×	0.8×	0.9×	0.9×	0.9×	—	—
Inventory turnover	14.1×	9.6×	21.6×	20.5×	22.8×	36.5×	—	—
Receivables turnover	17.3×	19.6×	21.5×	20.2×	19.9×	24.6×	—	—
Dividend payout	34.1%	33.8%	43.1%	56.2%	42.6%	44.1%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.